Text Size

Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by University Hospital, Angers.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT01052974
First received: January 19, 2010
Last updated: February 3, 2010
Last verified: January 2010
History of Changes
  Purpose

Therapeutic essay of phase IV, monocentric, prospective, randomized, in double-blind during 48 hours(then simple-blind),controlled by placebo.

Abstract:

The increasing incidence of the number of femoral neck fractures and the poor prognosis of this traumatological pathology involves an optimization of the diagnostic, therapeutic and analgesic care.

A widespread collectively practice for the analgesia in prehospital or preoperative period is the single injection ("single shot") of local anesthetic with the technique of the femoral or iliofascial block. Nevertheless the single injection of a dose of local anesthetic associated or not with analgesic adjuvants, due to their pharmacological properties, can't prolong the efficiency of the loco-regional analgesia more than 12 hours.

The aim of our study is to evaluate, in the patients admitted in emergencies for suspicion of femoral neck fractures, the perioperative efficiency of an analgesic treatment using a femoral perineural catheter (inserted from the hospital admission) with continuous infusion of ropivacaïne controlled by placebo (physiological serum).


Condition Intervention Phase
Femoral Neck Fracture
 Drug: ropivacaine
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol -

Resource links provided by NLM:

MedlinePlus related topics: Fractures
U.S. FDA Resources

Further study details as provided by University Hospital, Angers:

Primary Outcome Measures:
  • evaluate, in the patients admitted in emergencies for suspicion of femoral neck fractures, the perioperative efficiency of an analgesic treatment using a femoral perineural catheter [ Time Frame: from the hospital admission to 24h after surgical operation ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: March 2009
Estimated Study Completion Date: September 2010
Estimated Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: physiological serum
ropivacaïne controlled by placebo (physiological serum).
 Drug: ropivacaine

A widespread collectively practice for the analgesia in prehospital or preoperative period is the single injection of local anesthetic with the technique of the femoral or iliofascial block.

Intervention: Analgesic treatment using a femoral perineural catheter (inserted from the hospital admission) with continuous infusion of ropivacaïne controlled by placebo.
Active Comparator: ropivacaine
ropivacaïne controlled by placebo (physiological serum).
 Drug: ropivacaine

A widespread collectively practice for the analgesia in prehospital or preoperative period is the single injection of local anesthetic with the technique of the femoral or iliofascial block.

Intervention: Analgesic treatment using a femoral perineural catheter (inserted from the hospital admission) with continuous infusion of ropivacaïne controlled by placebo.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • femoral neck fracture

Exclusion Criteria:

  • Contraindication with analgesia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01052974

Contacts
Contact: Guillaume BOUHOURS 33-(0)2-41-35-36-35 gubouhours@chu-angers.fr

Locations
France
UHAngers Recruiting
Angers, France, 49 933
Contact: Guillaume BOUHOURS     33-(0)2-41-35-36-35     gubouhours@chu-angers.fr    
Principal Investigator: Guillaume BOUHOURS            
Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Guillaume BOUHOURS University Hospital, Angers
  More Information

No publications provided

Responsible Party: BOUHOURS, UHAngers
ClinicalTrials.gov Identifier: NCT01052974     History of Changes
Other Study ID Numbers: AOI2008-07
Study First Received: January 19, 2010
Last Updated: February 3, 2010
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Angers:
femoral neck fracture
analgesia

Additional relevant MeSH terms:
Femoral Neck Fractures
Fractures, Bone
Hip Fractures
Femoral Fractures
Wounds and Injuries
Leg Injuries
Ropivacaine
Anesthetics, Local
 Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on May 16, 2013